Cary Street Partners Investment Advisory’s Fresenius Medical Care FMS Stock Holding History
Bought
Maintained
Sold
Other funds holding FMS
FMI
Cary Street Partners Investment Advisory's FMS Position: Q4 2023 in Review
Cary Street Partners Investment Advisory sold out of Fresenius Medical Care (FMS) in Q4 2023, closing a stake of 238 shares — an estimated $5.13K sold.
Cary Street Partners Investment Advisory first reported a position in FMS in Q4 2022 and held it in 4 quarters. The position peaked at $5.7K in Q2 2023. 160 funds tracked by Wall St. Rank hold FMS as of Q4 2023.
- Cary Street Partners Investment Advisory reported no remaining Fresenius Medical Care position as of Q4 2023 after selling out during the quarter.
- Cary Street Partners Investment Advisory sold 238 Fresenius Medical Care shares in Q4 2023, an estimated $5.13K.
- Cary Street Partners Investment Advisory first reported a position in Fresenius Medical Care in Q4 2022 and held it in 4 quarters.
- Cary Street Partners Investment Advisory's Fresenius Medical Care position peaked at $5.7K in Q2 2023.
- 160 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2023.
Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.